NICE has been notified about this procedure and will consider it as part of its work programme. The Interventional Procedures Advisory Committee (IPAC) will consider this procedure and NICE will issue an interventional procedures consultation document about its safety and efficacy for 4 weeks’ public consultation. IPAC will then review the consultation document in the light of comments received and produce a final interventional procedures document, which will be considered by NICE before guidance is issued to the NHS in England, Wales, Scotland and Northern Ireland.
Status In progress
Process IP
ID number 1551
Description Low-level laser therapy aims to treat or prevent OM by promoting healing, reducing inflammation and increasing cell metabolism. A hand-held probe is used to deliver light in the red or near-infrared spectrum to the oral mucosa. It can be delivered intra-orally or extra-orally, or as a combination of both approaches. During intraoral treatment the probe, which is about the size of a dental curing light, is introduced into the mouth. For extraoral treatment the probe is positioned close to the cheek. The procedure typically takes 20 to 30 minutes, delivered 2 to 5 times a week for the duration of the oncology treatment. The procedure may be started before treatment with chemotherapy or radiotherapy begins, with the intention of preventing OM.


Key events during the development of the guidance:

Date Update
25 January 2018 - 22 February 2018 Interventional procedure consultation

For further information on how we develop guidance, please see our page about NICE interventional procedures guidance